Chemours (CC) Misses Q4 EPS by 12c

Chemours (NYSE: CC) reported Q4 EPS of $0.00, $0.12 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.26 billion.

For earnings history and earnings-related data on Chemours (CC) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• KB Home (KBH) PT Raised to $66 at UBS on Market Stabilisation and Execution
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance